Literature DB >> 19965587

Genetic and nongenetic sources of variation in phospholipid transfer protein activity.

Gail P Jarvik1, Ramakrishnan Rajagopalan, Elisabeth A Rosenthal, Gertrud Wolfbauer, Laura McKinstry, Aditya Vaze, John Brunzell, Arno G Motulsky, Deborah A Nickerson, Patrick J Heagerty, Ellen M Wijsman, John J Albers.   

Abstract

Phospholipid transfer protein (PLTP) belongs to the lipid transfer/lipopolysaccharide-binding protein gene family. Expression of PLTP has been implicated in the development of atherosclerosis. We evaluated the effects of PLTP region tagging single nucleotide polymorphisms (SNPs) on the prediction of both carotid artery disease (CAAD) and PLTP activity. CAAD effects were evaluated in 442 Caucasian male subjects with severe CAAD and 497 vascular disease-free controls. SNP prediction of PLTP transfer activity was evaluated in both a subsample of 87 subjects enriched for an allele of interest and in a confirmation sample of 210 Caucasian males and females. Hemoglobin A1c or insulin level predicted 11-14% of age- and sex-adjusted PLTP activity. PLTP SNPs that predicted approximately 11-30% of adjusted PLTP activity variance were identified in the two cohorts. For rs6065904, the allele that was associated with CAAD was also associated with elevated PLTP activity in both cohorts. SNPs associated with PLTP activity also predicted variation in LDL-cholesterol and LDL-B level only in the replication cohort. These results demonstrate that PLTP activity is strongly influenced by PLTP region polymorphisms and metabolic factors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19965587      PMCID: PMC2853466          DOI: 10.1194/jlr.M000125

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  47 in total

1.  Inference of population structure using multilocus genotype data.

Authors:  J K Pritchard; M Stephens; P Donnelly
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

2.  Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype.

Authors:  G P Jarvik; L S Rozek; V H Brophy; T S Hatsukami; R J Richter; G D Schellenberg; C E Furlong
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-11       Impact factor: 8.311

3.  The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression.

Authors:  N L Urizar; D H Dowhan; D D Moore
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

4.  PLTP activity in premenopausal women. Relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance.

Authors:  S J Murdoch; M C Carr; J E Hokanson; J D Brunzell; J J Albers
Journal:  J Lipid Res       Date:  2000-02       Impact factor: 5.922

5.  Glucose regulates the transcription of human genes relevant to HDL metabolism: responsive elements for peroxisome proliferator-activated receptor are involved in the regulation of phospholipid transfer protein.

Authors:  A Y Tu; J J Albers
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

6.  Relation of baseline plasma phospholipid transfer protein (PLTP) activity to left ventricular systolic dysfunction in patients referred for coronary angiography.

Authors:  Erdal Cavusoglu; Jonathan D Marmur; Sandeep Chhabra; Vineet Chopra; Calvin Eng; Xian-Cheng Jiang
Journal:  Atherosclerosis       Date:  2009-04-17       Impact factor: 5.162

7.  Elevation of systemic PLTP, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice.

Authors:  Hannelore Samyn; Matthijs Moerland; Teus van Gent; Rien van Haperen; Frank Grosveld; Arie van Tol; Rini de Crom
Journal:  Atherosclerosis       Date:  2008-10-30       Impact factor: 5.162

8.  Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology.

Authors:  Marian C Cheung; Gertrud Wolfbauer; Hiroshi Deguchi; José A Fernández; John H Griffin; John J Albers
Journal:  Biochim Biophys Acta       Date:  2008-12-30

9.  PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene study.

Authors:  Axel Schlitt; Stefan Blankenberg; Christoph Bickel; Karl J Lackner; Gunnar H Heine; Michael Buerke; Karl Werdan; Lars Maegdefessel; Uwe Raaz; Hans J Rupprecht; Thomas Munzel; Xian-Cheng Jiang
Journal:  J Lipid Res       Date:  2008-11-10       Impact factor: 5.922

10.  Novel roles of hepatic lipase and phospholipid transfer protein in VLDL as well as HDL metabolism.

Authors:  Rien van Haperen; Hannelore Samyn; Teus van Gent; Adri J Zonneveld; Matthijs Moerland; Frank Grosveld; Hans Jansen; Geesje M Dallinga-Thie; Arie van Tol; Rini de Crom
Journal:  Biochim Biophys Acta       Date:  2009-06-11
View more
  12 in total

1.  Impact of site-specific N-glycosylation on cellular secretion, activity and specific activity of the plasma phospholipid transfer protein.

Authors:  John J Albers; Joseph R Day; Gertrud Wolfbauer; Hal Kennedy; Simona Vuletic; Marian C Cheung
Journal:  Biochim Biophys Acta       Date:  2011-04-16

Review 2.  Genetic determinants of plasma triglycerides.

Authors:  Christopher T Johansen; Sekar Kathiresan; Robert A Hegele
Journal:  J Lipid Res       Date:  2010-11-01       Impact factor: 5.922

3.  PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activity.

Authors:  Daniel Seung Kim; Amber A Burt; Jane E Ranchalis; Simona Vuletic; Tomas Vaisar; Wan-Fen Li; Elisabeth A Rosenthal; Weijiang Dong; Jason F Eintracht; Arno G Motulsky; John D Brunzell; John J Albers; Clement E Furlong; Gail P Jarvik
Journal:  J Lipid Res       Date:  2015-05-25       Impact factor: 5.922

Review 4.  Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism.

Authors:  John J Albers; Simona Vuletic; Marian C Cheung
Journal:  Biochim Biophys Acta       Date:  2011-06-28

5.  Linkage and association of phospholipid transfer protein activity to LASS4.

Authors:  Elisabeth A Rosenthal; James Ronald; Joseph Rothstein; Ramakrishnan Rajagopalan; Jane Ranchalis; G Wolfbauer; John J Albers; John D Brunzell; Arno G Motulsky; Mark J Rieder; Deborah A Nickerson; Ellen M Wijsman; Gail P Jarvik
Journal:  J Lipid Res       Date:  2011-07-13       Impact factor: 5.922

Review 6.  Genetics of HDL-C: a causal link to atherosclerosis?

Authors:  Julian C van Capelleveen; Andrea E Bochem; M Mahdi Motazacker; G Kees Hovingh; John J P Kastelein
Journal:  Curr Atheroscler Rep       Date:  2013-06       Impact factor: 5.113

Review 7.  Phospholipid transfer protein: its impact on lipoprotein homeostasis and atherosclerosis.

Authors:  Xian-Cheng Jiang
Journal:  J Lipid Res       Date:  2018-02-08       Impact factor: 5.922

Review 8.  Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease.

Authors:  Christian Besler; Thomas F Lüscher; Ulf Landmesser
Journal:  EMBO Mol Med       Date:  2012-03-16       Impact factor: 12.137

9.  The I405V and Taq1B polymorphisms of the CETP gene differentially affect sub-clinical carotid atherosclerosis.

Authors:  Eliane Soler Parra; Natália Baratella Panzoldo; Denise Kaplan; Helena Coutinho Franco de Oliveira; José Ernesto dos Santos; Luiz Sérgio Fernandes de Carvalho; Andrei Carvalho Sposito; Magnus Gidlund; Ruy Tsutomu Nakamura; Vanessa Helena de Souza Zago; Edna Regina Nakandakare; Eder Carlos Rocha Quintão; Eliana Cotta de Faria
Journal:  Lipids Health Dis       Date:  2012-10-05       Impact factor: 3.876

10.  Niacin Increases Atherogenic Proteins in High-Density Lipoprotein of Statin-Treated Subjects.

Authors:  Graziella E Ronsein; Tomas Vaisar; W Sean Davidson; Karin E Bornfeldt; Jeffrey L Probstfield; Kevin D O'Brien; Xue-Qiao Zhao; Jay W Heinecke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-06-17       Impact factor: 10.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.